Jan Wise
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jan Wise has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Asilay Seker
Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
1 shared publication - Brechje Dandachi-FitzGerald
Faculty of Psychology, Open University, Heerlen, The Netherlands
1 shared publication - Cecile Hanon
Regional Resource Center of Old Age Psychiatry, AP-HP, Centre - University of Paris, Paris, France
1 shared publication - Dawn Collins
Norfolk and Suffolk NHS Foundation Trust
1 shared publication - Defne Eraslan
SRH Klinikum Karlsbad-Langensteinbach GmbH
1 shared publication - Harald Merckelbach
Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 24 November 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-35
Suicide prediction, prevention, and the blame culture: A narrative review based on trends in mortality rates
Background: Suicide involves an act of volition on the part of the deceased, making it unlike deaths from physical disorders such as cancer or stroke. The latter occur passively and often despite the efforts of the patient to stay alive. Yet when there is a suicide, clinicians involved may often be blamed and families may often feel guilt. This contrasts with the default response of praise and thanks to clinicians following treatment preceding deaths from physical disorders. Methods: Comparative standardized mortality rate (SMR) data are analyzed to demonstrate the impact of developments in care over the past two decades in the United Kingdom (UK), and similar United States (USA) SMR data are noted. The evidence is reviewed regarding our ability to predict who will die by suicide, when and where to target intervention, and practical and effective prevention methods. Results: Data from the UK are presented that reflects the relative lack of impact of prevention efforts on suicide mortality rates when compared to the reductions seen in various physical disorders. This narrative review comments on the causes and consequences of this difference. Conclusions: The challenge for psychiatry is that SMR data suggest that we have been unable to significantly reduce suicide SMR unlike that for physical disorders. This needs to be fully acknowledged and the biased assumption of blame needs to stop. The focus needs to be on evidence-based interventions that do work, such as medications, psychological treatments, psychological interventions, and suicide prevention research.
- 24 November 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-35
Open AccessSuicide prediction, prevention, and the blame culture: A narrative review based on trends in mortality rates
Background: Suicide involves an act of volition on the part of the deceased, making it unlike deaths from physical disorders such as cancer or stroke. The latter occur passively and often despite the efforts of the patient to stay alive. Yet when there is a suicide, clinicians involved may often be blamed and families may often feel guilt. This contrasts with the default response of praise and thanks to clinicians following treatment preceding deaths from physical disorders. Methods: Comparative standardized mortality rate (SMR) data are analyzed to demonstrate the impact of developments in care over the past two decades in the United Kingdom (UK), and similar United States (USA) SMR data are noted. The evidence is reviewed regarding our ability to predict who will die by suicide, when and where to target intervention, and practical and effective prevention methods. Results: Data from the UK are presented that reflects the relative lack of impact of prevention efforts on suicide mortality rates when compared to the reductions seen in various physical disorders. This narrative review comments on the causes and consequences of this difference. Conclusions: The challenge for psychiatry is that SMR data suggest that we have been unable to significantly reduce suicide SMR unlike that for physical disorders. This needs to be fully acknowledged and the biased assumption of blame needs to stop. The focus needs to be on evidence-based interventions that do work, such as medications, psychological treatments, psychological interventions, and suicide prevention research.
- Open Access
- 13 November 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 32 (4) , 221-230
The place of validity tests in psychiatric diagnosis: beyond common misconceptions
SUMMARY: Validity tests are used in both forensic and clinical settings, but their application in clinical practice is often hindered by misconceptions. These include the assumptions that validity tests imply a medico-legal dimension, primarily detect feigning or malingering, and provide minimal actionable information to clinicians. The authors critically discuss these misconceptions and argue that validity tests may offer significant value in clinical practice by assessing whether patients can describe their symptoms, complaints and impairments with reasonable accuracy, which has important implications for diagnosis and treatment planning. Importantly, in clinical practice, when interpreting validity tests, neutral terminology such as ‘over-reporting’ and ‘underperformance’ is often preferable to – and better to substantiate than – terms like ‘feigning’ and ‘malingering’, which can evoke moral judgements, creating an unnecessary barrier to using these valuable clinical tools.
- 13 November 2025
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 32 (4) , 221-230
Open AccessThe place of validity tests in psychiatric diagnosis: beyond common misconceptions
SUMMARY: Validity tests are used in both forensic and clinical settings, but their application in clinical practice is often hindered by misconceptions. These include the assumptions that validity tests imply a medico-legal dimension, primarily detect feigning or malingering, and provide minimal actionable information to clinicians. The authors critically discuss these misconceptions and argue that validity tests may offer significant value in clinical practice by assessing whether patients can describe their symptoms, complaints and impairments with reasonable accuracy, which has important implications for diagnosis and treatment planning. Importantly, in clinical practice, when interpreting validity tests, neutral terminology such as ‘over-reporting’ and ‘underperformance’ is often preferable to – and better to substantiate than – terms like ‘feigning’ and ‘malingering’, which can evoke moral judgements, creating an unnecessary barrier to using these valuable clinical tools.